Related Topics News -

     
 Detail   |   Print 
     
翰森製藥奧萊泊肽注射液上市許可申請獲內地受理
2026-06-04T  
《季檢》國指加入翰森康方生物 剔出海爾智家
2026-05-22T  
翰森製藥旗下藥物用於非小細胞肺癌納入突破性治療藥物
2026-05-22T  
翰森製藥HS-10541片獲批臨床
2026-05-14T  
翰森製藥HS-20093用於食管鱗癌納入突破性治療藥物
2026-05-11T  
翰森製藥將KiOmedine One開發及商業化權利轉予恆瑞醫藥 套現1.31億人幣
2026-04-30T  
翰森製藥注射用HS-20093獲納入突破性治療藥物
2026-04-30T  
翰森製藥HS-10522片獲兩項臨床試驗批准
2026-04-30T  
翰森製藥HS-20093聯合阿得貝利單抗獲納入突破性治療藥物
2026-04-16T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.